U.S. Water Utilities Stock News

Marex Group plc recently presented at the Morgan Stanley US Financials Conference 2026 in New York and, on June 8, 2026, appointed fintech entrepreneur and private credit specialist Georges Assi to its Group Board and Risk Committee. Investor commentary from Night Watch Investment Management has put a spotlight on Marex’s earnings profile and role in volatile markets, drawing attention to how its business model performs across shifting trading conditions. We’ll now explore how the...

Over the past three months, PBF Energy (NYSE:PBF) has seen substantial insider selling activity, with no corresponding insider purchases reported. This pattern coincides with cautious analyst sentiment on the stock and raises fresh questions about internal confidence. The scale and persistence of selling stand out as material developments for investors tracking corporate governance and insider behavior. PBF Energy operates as an independent refiner and supplier of transportation fuels and...

If you are wondering whether Credicorp stock is still reasonably priced after a strong run, the next sections will walk through what the current market price might be implying about its value. Credicorp recently closed at US$362.32, with returns of 13.3% over the past week, 14.5% over the past month, 26.5% year to date and 73.9% over the last year. The 3 year and 5 year returns stand at 188.6% and 305.6% respectively. Recent trading interest has been shaped by ongoing coverage of Credicorp...

BOK Financial (BOKF) stock has been drawing attention after recent trading, with shares last closing at $132.05. Investors are weighing this price against the bank’s earnings profile, regional footprint, and recent return trends. See our latest analysis for BOK Financial. Short term trading in BOK Financial has been mixed, with the share price slipping 1.90% over the last day but posting an 11.27% year to date share price return and a 45.28% total shareholder return over one year. This...

Elicio Therapeutics recently reported that its Phase 2 AMPLIFY-7P trial of ELI-002 7P in adjuvant pancreatic cancer did not meet the pre-specified primary disease-free survival endpoint in the intent-to-treat population, although the company highlighted imbalances in high-risk R1 resections between treatment and observation arms. Post-hoc analyses showed improved disease-free survival and strong mutant KRAS-specific immune responses in R0 resected patients, prompting Elicio to redesign a...

Advanced Micro Devices (AMD) has drawn fresh attention after recent trading data showed strong share price momentum over the past month and past 3 months, prompting investors to reassess how the stock aligns with their portfolios. See our latest analysis for Advanced Micro Devices. Beyond the recent surge, Advanced Micro Devices has seen momentum build over the past year, with a 90 day share price return of 174.37% and a 1 year total shareholder return of 330.57% on the back of growing...

DICK'S Sporting Goods recently announced a partnership with Lids to roll out immersive, branded Lids shops inside its stores, expanding access to licensed and lifestyle headwear, while also reporting a 6% increase in comparable store sales year-over-year amid management’s cautious comments on the broader economy. Alongside this in-store collaboration, bondholders face a new fixed-income exchange offer on the company’s 4.000% notes due October 1, 2029, while shareholders recently voted...

Recent commentary on Enerpac Tool Group highlighted ongoing strength in its Industrial Tools & Services segment and the contribution from its DTA acquisition, with fiscal 2026 earnings consensus remaining steady over the past 60 days. This combination of segment momentum and acquisition-driven expansion is drawing investor attention to how Enerpac is consolidating its position within the Manufacturing-Tools & Related Products industry despite cost and supply-chain pressures. We’ll now...

In the past quarter ended April 30, 2026, Rubrik, Inc. reported revenue of US$387.07 million, up from US$278.48 million a year earlier, while its net loss narrowed to US$41.85 million and basic loss per share improved to US$0.21 from US$0.53. Alongside confirming second-quarter revenue guidance of US$395 million to US$397 million, Rubrik raised its full-year Fiscal 2027 revenue outlook to a range of US$1.64 billion, signaling management’s confidence in its data security business...

The Goodyear Tire & Rubber Company recently announced it will supply advanced lunar tires for Lunar Outpost’s Pegasus Lunar Terrain Vehicle, designed to support astronaut missions at the Moon’s South Pole from 2028. This lunar program highlights how Goodyear is applying its extreme-environment tire technology beyond Earth, reinforcing its innovation credentials in high-performance mobility solutions. We’ll now examine how Goodyear’s role in Pegasus, alongside easing Strait of Hormuz...

Recursion Pharmaceuticals (RXRX) is back in focus after recent clinical updates on its AI-driven pipeline and in advance of its presentation at the Goldman Sachs Global Healthcare Conference in Miami on June 9, 2026. See our latest analysis for Recursion Pharmaceuticals. Despite the recent 4.44% 1 day share price gain to US$3.29 and a 12.29% 1 month share price return that reflects fresh interest around Recursion Pharmaceuticals' AI platform and trial updates, longer term total shareholder...

Earlier in June 2026, a Delaware jury found that Amgen willfully infringed Harbour BioMed’s Grosveld patent, awarding Harbour US$20,203,704 in damages, while Amgen also released new Phase 3 VESALIUS-CV data showing Repatha reduced major cardiovascular events in high-risk diabetes patients and secured European approval for its lung cancer drug Imdylltra. The combination of a patent loss in antibody discovery technology and clinically meaningful Repatha outcomes, alongside Imdylltra’s new EU...

If you are wondering whether DRDGOLD stock still offers value after its strong run, this article focuses squarely on what the numbers say about price versus fundamentals. At a last close of US$25.19, DRDGOLD has returned 6.3% over the past week, while its 1 year return of 74.0% sits alongside a year to date decline of 16.9% and a 30 day decline of 4.0%. This combination may signal shifting expectations around risk and opportunity. Recent coverage of DRDGOLD has centered on its share price...

Mosaic (MOS) is back on investors’ radar after a series of broker upgrades and a new China U.S. agricultural trade deal that points to stronger medium term fertilizer demand. See our latest analysis for Mosaic. Despite a recent bounce helped by broker upgrades and the China U.S. farm deal, Mosaic’s 1-year total shareholder return is down 35.27%, and its 5-year total shareholder return is down 17.69%, showing recent momentum but a weaker longer-term record. If this kind of cyclical setup...

Yum! Brands (NYSE:YUM) is piloting a new KFC "Open House" restaurant concept in McKinney, Texas. The prototype is designed to create a more contemporary, hospitality-focused dining experience for customers. The format reflects an emphasis on younger, more tech-oriented guests and updated in-restaurant engagement. Yum! Brands, through KFC, is testing this Open House concept at a time when quick-service chains are rethinking how physical restaurants support digital ordering and changing...

Dividend announcement and what it means for TKO Group Holdings stock TKO Group Holdings (TKO) announced that its board has declared a quarterly cash dividend of $0.79 per Class A share, tied to an aggregate distribution of about $150 million. The dividend is scheduled to be paid on June 30, 2026 to Class A stockholders of record as of the close of business on June 15, 2026, with an ex dividend date also set for June 15. See our latest analysis for TKO Group Holdings. At a share price of...

With inflation and interest rate policies moving in different directions around the world, many investors are looking for ways to stay exposed to growth without taking on excessive balance sheet risk. That is where the Financially Fit Penny Stocks screener comes in, focusing on lower priced companies that aim to pair early stage potential with healthier finances than typical micro caps. This article highlights three stocks from that screener, giving you a clear, practical starting point if...

Bristol-Myers Squibb (BMY) stock is back in focus after the company expanded its kidney cancer trial through a clinical collaboration with Arcus Biosciences, adding new casdatifan arms to the ROSETTA RCC-208 study. See our latest analysis for Bristol-Myers Squibb. The kidney cancer trial expansion comes after a mixed period for Bristol-Myers Squibb, with the share price at $56.24, a year to date share price return of 5.2%, and a 1 year total shareholder return of 21.35%. This suggests...

How McGrath RentCorp stock has been performing McGrath RentCorp (MGRC) has drawn investor attention after a period of steady share price movement, with the stock last closing at US$114.18 and posting mixed short term and longer term returns. Over the past day, McGrath RentCorp declined 0.79%, while it gained 4.46% over the past week and 2.17% over the past month. Looking further back, the stock is up 8.21% over the past 3 months, with a 3.29% total return over the past year and a 27.09% total...

Recent analyst activity around Sterling Infrastructure (STRL) has centered on a cluster of strong buy style ratings supported by upward revisions to earnings estimates, a combination that can draw fresh attention to the stock. See our latest analysis for Sterling Infrastructure. At a latest share price of $866.67, Sterling Infrastructure has seen strong momentum, with the 90 day share price return above 100% and a very large 5 year total shareholder return. This contrasts with a softer 7 day...

Innodata (NasdaqGM:INOD) reported record Q1 results, supported by a broader and expanding set of large technology customers. The company raised its full year revenue growth guidance for 2026 following the strong quarter. Innodata enters this new phase with its share price at $99.66 and a very large 5 year return of 1,295.8%. The stock is also up 88.1% year to date and 123.6% over the past year, reflecting recent share price momentum. For investors, the latest update comes on top of these...

The Trump administration’s newly announced peace deal to reopen the Strait of Hormuz has put Woodward (WWD) in focus, as investors rethink demand for aerospace equipment tied to commercial air travel routes. See our latest analysis for Woodward. Beyond the peace deal headlines, Woodward’s share price has been strong, with a 1-day share price return of 4.05% and a year-to-date share price return of 29.48%. The 1-year total shareholder return of 72% and 3-year total shareholder return above...

In recent weeks, Symbotic Inc., a warehouse automation technology company, has drawn increased investor scrutiny over its valuation and execution risks ahead of its upcoming earnings report. Despite management guiding for Q3 revenue of US$700 million to US$720 million and adjusted EBITDA of US$80 million to US$85 million, concerns about backlog conversion timing, margin durability, and customer concentration are shaping how investors assess the business. We’ll now examine how this...

Pharvaris (NasdaqGS:PHVS) stock is in focus after the company reported detailed Phase 3 RAPIDe-3 and long-term CHAPTER-1 data for its oral hereditary angioedema therapy deucrictibant at the EAACI 2026 Congress. See our latest analysis for Pharvaris. Against this backdrop of detailed Phase 3 data and conference activity, Pharvaris stock has a 90 day share price return of 17.16% and a 1 year total shareholder return of 85.97%, suggesting building momentum as investors respond to the HAE program...